Navigation Links
Novartis Consumer Health Inc. Issues Voluntary Nationwide Recall of Certain Over-the-Counter Products Due to Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps
Date:1/8/2012

 100008020

Excedrin® Extra Strength  Tablets 300CT New Label

300672030337

10300672030310

0067203033

 100003134

Excedrin® Extra Strength  Tablets 300S

300672030337

10300672030334

0067203033

 100003186

Excedrin® Extra Strength  Tablets 50CT

300672030504

10300672030501

0067203050

 100008009

Excedrin® Extra Strength  Tablets 50CT New Label

300672030504

10300672030501

0067203050

 100006967

Excedrin® Extra Strength  Tablets 8CT

300672030085

10300672030082

0067203008

 100008007

Excedrin® Extra Strength  Tablets 8CT New Label

300672030085

10300672030082

0067203008

 100007967

Excedrin® Migraine  Express Gel Caplets 20CT New Label

300676341200

10300676341207

0067634120

 100003178

Excedrin® Migraine Caplets 100CT

300672039910

10300672039917

0067203991

 100005998

Excedrin® Migraine Caplets 100CT Account Specific

300672039941

10300672039948

0067203994

 100008087

Excedrin® Migraine Caplets 100CT Account Specific No Carton

300672039941

10300672039948

0067203994

 100008656

Excedrin® Migraine Caplets 100CT Account Specific

300672043917

10300672043914

0067203991

 100008086

Excedrin® Migraine Caplets 100CT New Label

300672039910

10300672039917

0067203991

 100008443

Excedrin® Migraine Caplets 125CT Bonus Pack No Carton

300672039842

10300672039849

0067203984'/>"/>

SOURCE Novartis Consumer Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec®
2. New Data Confirms Novartis Drug Afinitor® Significantly Extends Time Women With Advanced Breast Cancer Live Without Tumor Growth
3. Novartis Study Shows QTI571 Significantly Improved Walking Distance in Patients with Life-Threatening Pulmonary Arterial Hypertension
4. Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
5. Novartis Study Showed ACZ885 Provided Substantial Symptom Relief in 84% of Patients With the Most Serious Form of Childhood Arthritis
6. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
7. Novartis Drug Gleevec® Shows Significant Overall Survival Benefit for Patients With GIST After Three Years of Adjuvant Treatment vs. One Year
8. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
9. Novartis Data Shows ACZ885 for Severe Gouty Arthritis Provided Better Pain Relief and Reduced Risk of New Attacks by Up to 68% vs. Steroid
10. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
11. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015 Semler Scientific, ... assessment company that develops, manufactures and markets products that ... diseases, today reported financial results for the first quarter ... first quarter of 2015, Semler reported continued progress with ... over quarter revenue growth of 14%," said Doug ...
(Date:5/1/2015)... , May 1, 2015  Shares of Aerie Pharmaceuticals, ... their value yesterday following the results of the Phase ... Rhopressa.  Despite the trial failing to meet its end ... results may come from future studies. An ... overview, current pipeline, financial review, analyst summary, valuation, and ...
(Date:4/30/2015)... , April 30, 2015  Accuray Incorporated (Nasdaq: ... signed an agreement with MIM Software Inc. to ... ® and CyberKnife ® product portfolios. The ... MIM technology. This is Accuray,s second collaboration with ... of the first iPad-based treatment plan review capability, ...
Breaking Medicine Technology:Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 3
... who take non-steroidal anti-inflammatory drugs three times a day for ... have erectile dysfunction compared to men who do not take ... online in The Journal of Urology . ... finding, this observational study used electronic health records, an automated ...
... Md., March 2, 2011 Do you use a prescription ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Federal regulators aim to take certain ... symptoms off the U.S. market. These products ... evaluated by FDA to assure that they are safe, effective, ...
Cached Medicine Technology:Non-Steroidal Anti-Inflammatory Drugs Linked to Increased Risk of Erectile Dysfunction 2Non-Steroidal Anti-Inflammatory Drugs Linked to Increased Risk of Erectile Dysfunction 3
(Date:5/2/2015)... May 03, 2015 As one of ... the prestigious Safety and Health Achievement and Recognition Program ... to be chosen by the Illinois Department of Labor ... achieved and maintained SHARP certification by the Occupational Safety ... as Essentra has continued to meet or exceed all ...
(Date:5/2/2015)... 2015 It’s a pattern that won’t ... strikes anywhere on this planet, cyber scammers will immediately ... compassion for their own personal gain. And on ... Team) issued an alert titled “Nepal Earthquake Disaster ... citing the earthquake in Nepal. The scam emails may ...
(Date:5/2/2015)... 2015 As a nonsurgical staple ... the face, neck and décolleté, radiofrequency energy is ... potential for the success of vulvovaginal rejuvenation. In ... Advisory Council, ThermiGyn’s Women’s Health Clinical Advisory Board ... that ThermiGyn’s temperature controlled radio frequency, specifically that ...
(Date:5/1/2015)... Pioneer Millworks, the largest reclaimed wood ... their reclaimed wood products at the 27th annual International ... in NYC this May. Their newest offerings, Vat 35, ... texture and color to North America's platform for global ... and color in the design world and we're excited ...
(Date:5/1/2015)... 2015 It’s raining bills on Capitol Hill ... to expand federal support for telemedicine. , “Such ... been working with Congress,” said Jonathan Linkous, CEO of the ... nation is poised to embrace the use of telecommunications in ... in fulfilling ATA’s mission to improve quality, access, equity and ...
Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2
... Water Quality and Health Council Calls for Greater Surface Disinfection to ... you cough without covering your mouth while standing in the lunch ... the morning bus? Nearly all Americans (96 percent) have seen ... (77 percent) say they are guilty themselves. , Even with ...
... ... the launch of MethoCult® Express, an innovative methylcellulose-based medium specifically formulated to allow ... , ... British Columbia (PRWEB) October 8, 2009 -- STEMCELL Technologies Inc. , a ...
... ... a leading direct-to-consumer provider of premium dietary supplements, announces the release of their ... ... Products ®, a leading direct-to-consumer provider of premium dietary supplements, announces the release ...
... acute liver failure caused by acetaminophen poisoning also can treat ... before severe injury occurs, UT Southwestern Medical Center researchers and ... liver failure occurs when cells in the liver die quickly, ... Patients often end up in a hepatic coma as a ...
... SAN BERNARDINO, Calif., Oct. 7 Last Sunday, the Inland ... Historic Redlands to fight cancer. With more than 6,000 ... Inland Women Fighting Cancer,s 2nd Annual Believe and Walk ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20091007/LA89260LOGO ) , The sea of ...
... Center,s Health Care Report Urge Joint Leadership on Health Reform ... statement released by Bipartisan Policy Center Founders and Advisory Board ... , "After 14 months of work, on June 17, 2009, ... the culmination of months of work as advisors to the ...
Cached Medicine News:Health News:Gross Germ-Spreading Behaviors Remain the Norm, Despite Flu Season Concerns 2Health News:Gross Germ-Spreading Behaviors Remain the Norm, Despite Flu Season Concerns 3Health News:STEMCELL Technologies Inc. Introduces MethoCult Express for Cord Blood Banks and Transplant Centers 2Health News:Purity Products Releases Their Brand New Mediterranean Diet Resveratrol Formula 2Health News:Medication effective for acute liver failure in early stages of disease 2Health News:Stater Bros. Charities Collects $328,000 for the Cure in 'I Believe Walk'... Over 6,000 Participate 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: